Lv1
20 积分 2025-07-22 加入
A guide for Gensini Score calculation
1个月前
已完结
Evolocumab Achieves Low LDL Cholesterol Without Long-Term Cognitive Risks
2个月前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
3个月前
已完结
PCSK9-directed therapies: an update
3个月前
已完结
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
3个月前
已完结
Oral PCSK9 Inhibitors: Will They Work?
3个月前
已完结
AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial
3个月前
已完结
Oral PCSK9 Inhibitors
3个月前
已完结
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome
5个月前
已完结
PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1
5个月前
已完结
皖公网安备34019202002308
